On August 24, 2023, Forte Biosciences, Inc announced that it has received shareholder proposal from Funicular Funds, LP, a partner to Cable Car Capital LLC requesting the board of directors to take all steps necessary to terminate without delay the preferred stock rights agreement, dated as of July 12, 2022, as amended on June 26, 2023.Further, Forte Biosciences, Inc stated that the board recommended shareholders to vote against the shareholder proposal at the annual meeting of shareholders to be held on September 19, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.725 USD | +1.21% | -1.84% | -11.77% |
Mar. 18 | Forte Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 05 | Camac Partners Provides Information to Shareholders | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.77% | 26.07M | |
-2.63% | 103B | |
+1.62% | 95.28B | |
+1.46% | 22.15B | |
-16.67% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.21% | 16.05B | |
+5.41% | 13.68B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- FBRX Stock
- News Forte Biosciences, Inc.
- Forte Biosciences, Inc Receives Shareholder Proposal from Funicular Funds, LP